JN

Jerry Nzerem

TI Theravance Biopharma R&D Ip: 4 patents #9 of 51Top 20%
📍 South San Francisco, CA: #21 of 270 inventorsTop 8%
🗺 California: #6,166 of 67,890 inventorsTop 10%
Overall (2019): #52,443 of 560,194Top 10%
4
Patents 2019

Issued Patents 2019

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
10493077 Fused imidazo-piperidine JAK inhibitor compound Paul R. Fatheree, Lan Jiang, Venkat R. Thalladi, Marta Dabros 2019-12-03
10392368 Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Erik Fenster, Tom M. Lam, Mandy Loo, Robert Murray McKinnell, Anthony Francesco Palermo +5 more 2019-08-27
10308646 Pyrimidine compound as JAK kinase inhibitor Jennifer Kozak, Ryan Hudson, Gary E. L. Brandt, Robert Murray McKinnell, Marta Dabros 2019-06-04
10251874 Crystalline forms of a JAK inhibitor compound Marta Dabros, Venkat R. Thalladi, Melanie A. Kleinschek, Glenn D. Crater 2019-04-09